Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | glycine receptor subunit beta | 0.0145 | 0.0129 | 0.0129 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.1385 | 1 | 0.5 |
Echinococcus granulosus | glycine receptor subunit alpha 1 | 0.0145 | 0.0129 | 0.0129 |
Echinococcus granulosus | glycine receptor subunit alpha 1 | 0.0145 | 0.0129 | 0.0129 |
Schistosoma mansoni | hypothetical protein | 0.1385 | 1 | 1 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.1385 | 1 | 0.5 |
Echinococcus multilocularis | glycine receptor subunit beta | 0.0145 | 0.0129 | 0.0129 |
Echinococcus granulosus | Cys loop ligand gated ion channel subunit | 0.0145 | 0.0129 | 0.0129 |
Echinococcus multilocularis | glycine receptor subunit alpha 1 | 0.0145 | 0.0129 | 0.0129 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.1385 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.0019 | 0.1437 |
Echinococcus multilocularis | glycine receptor subunit beta | 0.0145 | 0.0129 | 0.0129 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.1385 | 1 | 0.5 |
Brugia malayi | glutamate-gated chloride channel alpha3A subunit, putative | 0.0131 | 0.0019 | 0.1437 |
Loa Loa (eye worm) | GABA receptor subunit | 0.0131 | 0.0019 | 0.1437 |
Echinococcus multilocularis | Cys loop ligand gated ion channel subunit | 0.0145 | 0.0129 | 0.0129 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.1385 | 1 | 0.5 |
Echinococcus multilocularis | glycine receptor subunit alpha 1 | 0.0145 | 0.0129 | 0.0129 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.1385 | 1 | 0.5 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.1385 | 1 | 0.5 |
Echinococcus multilocularis | glycine receptor subunit alpha 1 | 0.0145 | 0.0129 | 0.0129 |
Echinococcus granulosus | glycine receptor subunit beta | 0.0145 | 0.0129 | 0.0129 |
Giardia lamblia | Rrm3p helicase | 0.1385 | 1 | 0.5 |
Brugia malayi | Cation transporter family protein | 0.0145 | 0.0129 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1385 | 1 | 0.5 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.1385 | 1 | 0.5 |
Echinococcus granulosus | glycine receptor subunit alpha 1 | 0.0145 | 0.0129 | 0.0129 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.1385 | 1 | 1 |
Loa Loa (eye worm) | glutamate-gated chloride channel alpha3A subunit | 0.0145 | 0.0129 | 1 |
Entamoeba histolytica | hypothetical protein, conserved | 0.1385 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.0129 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.56 uM | Activity at human alpha1betaGlyR expressed in HEK293 cells by FMP assay | ChEMBL. | 17352465 |
IC50 (binding) | = 0.65 uM | Activity at human alpha1GlyR expressed in HEK293 cells assessed as inhibition of 300 uM glycine-induced current by whole-cell patch clamp experiment | ChEMBL. | 17352465 |
IC50 (binding) | = 0.78 uM | Activity at human alpha1GlyR expressed in HEK293 cells by FMP assay | ChEMBL. | 17352465 |
IC50 (binding) | = 1.3 uM | Activity at human alpha2GlyR expressed in HEK293 cells by FMP assay | ChEMBL. | 17352465 |
Log IC50 (binding) | = 5.9 | Activity at human alpha2GlyR expressed in HEK293 cells by FMP assay | ChEMBL. | 17352465 |
Log IC50 (binding) | = 6.1 | Activity at human alpha1GlyR expressed in HEK293 cells by FMP assay | ChEMBL. | 17352465 |
Log IC50 (binding) | = 6.3 | Activity at human alpha1betaGlyR expressed in HEK293 cells by FMP assay | ChEMBL. | 17352465 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.